Low-grade and high-grade mammary carcinomas in WAP-T transgenic mice are independent entities distinguished by Met expression

International Journal of Cancer

Volumn 132, Issue 6, 2013, Pages 1300-1310

  Otto, Benjamin ^a   Gruner, Katharina ^a,b   Heinlein, Christina ^b   Wegwitz, Florian ^a,b   Nollau, Peter ^a   Ylstra, Bauke ^c   Pantel, Klaus ^a   Schumacher, Udo ^a   Baumbusch, Lars O ^d   Martin Subero, José Ignacio ^e   Siebert, Reiner ^e   Wagener, Christoph ^a   Streichert, Thomas ^a   Deppert, Wolfgang ^a,b   Tolstonog, Genrich V ^a,b,f  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

aCGH; gene expression; mammary carcinoma; Met signaling; mouse model

Indexed keywords

CYTOKERATIN 14; SCATTER FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE OVEREXPRESSION; MET GENE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; CELL LINE, TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MILK PROTEINS; NEOPLASM GRADING; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-MET; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84872915089     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27783     Document Type: Article

References (49)

1. Allred DC, Medina D,. The relevance of mouse models to understanding the development and progression of human breast cancer. J Mammary Gland Biol Neoplasia 2008; 13: 279-88.
2. Vargo-Gogola T, Rosen JM,. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007; 7: 659-72. (Pubitemid 47327411)
3. Heinlein C, Krepulat F, Lohler J, et al. Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis. Int J Cancer 2008; 122: 1701-9. (Pubitemid 351413415)
4. Schulze-Garg C, Lohler J, Gocht A, et al. A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland. Oncogene 2000; 19: 1028-37. (Pubitemid 30153786)
5. Kordon EC, McKnight RA, Jhappan C, et al. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev Biol 1995; 168: 47-61.
6. Robinson GW, McKnight RA, Smith GH, et al. Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 1995; 121: 2079-90.
7. Pipas JM,. SV40: cell transformation and tumorigenesis. Virology 2009; 384: 294-303.
8. Goetz F, Tzeng YJ, Guhl E, et al. The SV40 small t-Antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-Antigen molecules harboring the intact p53 and pRb binding region do not have this effect. Oncogene 2001; 20: 2325-32. (Pubitemid 32531291)
9. Barsotti AM, Prives C,. Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene 2009; 28: 4295-305.
10. Deeb KK, Michalowska AM, Yoon CY, et al. Identification of an integrated SV40 T/t-Antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Res 2007; 67: 8065-80. (Pubitemid 47395141)
11. Klein A, Guhl E, Zollinger R, et al. Gene expression profiling: cell cycle deregulation and aneuploidy do not cause breast cancer formation in WAP-SVT/t transgenic animals. J Mol Med 2005; 83: 362-76. (Pubitemid 41201801)
12. Wegwitz F, Kluth MA, Manz C, et al. Tumorigenic WAP-T mouse mammary carcinoma cells: A model for a self-reproducing homeostatic cancer cell system. PLoS One 2010; 5: e12103.
13. Li Z, Tognon CE, Godinho FJ, et al. ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 2007; 12: 542-58. (Pubitemid 350199073)
14. Santarelli R, Tzeng YJ, Zimmermann C, et al. SV40 T-Antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals. Oncogene 1996; 12: 495-505. (Pubitemid 26059643)
15. Husler MR, Kotopoulis KA, Sundberg JP, et al. Lactation-induced WAP-SV40 Tag transgene expression in C57BL/6J mice leads to mammary carcinoma. Transgenic Res 1998; 7: 253-63. (Pubitemid 28541850)
16. Herschkowitz JI, Simin K, Weigman VJ, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007; 8: R76.
17. Goecks J, Nekrutenko A, Taylor J,. Galaxy: A comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 2010; 11: R86.
18. Santarius T, Shipley J, Brewer D, et al. A census of amplified and overexpressed human cancer genes. Nat Rev Cancer 2010; 10: 59-64.
19. Peschard P, Fournier TM, Lamorte L, et al. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell 2001; 8: 995-1004. (Pubitemid 34031802)
20. Trusolino L, Bertotti A, Comoglio PM,. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010; 11: 834-48.
21. Boccaccio C, Comoglio PM,. Invasive growth: A MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 2006; 6: 637-45. (Pubitemid 44140861)
22. Gilles C, Polette M, Birembaut P, et al. Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines. Clin Exp Metastasis 1997; 15: 519-26. (Pubitemid 27323901)
23. Thuault S, Valcourt U, Petersen M, et al. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 2006; 174: 175-83. (Pubitemid 44079853)
24. Cannito S, Novo E, Compagnone A, et al. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 2008; 29: 2267-78.
25. Jones L, Wei G, Sevcikova S, et al. Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. J Exp Med 2010; 207: 2581-94.
26. Smolen GA, Muir B, Mohapatra G, et al. Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis. Cancer Res 2006; 66: 3452-5.
27. Graveel CR, DeGroot JD, Su Y, et al. Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer. Proc Natl Acad Sci USA 2009; 106: 12909-14.
28. Klijn C, Holstege H, de Ridder J, et al. Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data. Nucleic Acids Res 2008; 36: e13.
29. Liu P, Cheng H, Santiago S, et al. Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms. Nat Med 2011; 17: 1116-20.
30. Xu K, Usary J, Kousis PC, et al. Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer. Cancer Cell 2012; 21: 626-41.
31. Andrechek ER, Hardy WR, Siegel PM, et al. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci USA 2000; 97: 3444-9. (Pubitemid 30183322)
32. Sbrana I, Zavattari P, Barale R, et al. Common fragile sites on human chromosomes represent transcriptionally active regions: evidence from camptothecin. Hum Genet 1998; 102: 409-14. (Pubitemid 28203981)
33. Gottipati P, Helleday T,. Transcription-Associated recombination in eukaryotes: link between transcription, replication and recombination. Mutagenesis 2009; 24: 203-10.
34. Chan KL, Palmai-Pallag T, Ying S, et al. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat Cell Biol 2009; 11: 753-60.
35. Hwang CI, Matoso A, Corney DC, et al. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci USA 2011; 108: 14240-5.
36. Ponzo MG, Lesurf R, Petkiewicz S, et al. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc Natl Acad Sci USA 2009; 106: 12903-8.
37. Forbes SA, Bindal N, Bamford S, et al. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res 2011; 39: D945-50.
38. Carracedo A, Egervari K, Salido M, et al. FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors. Breast Cancer Res 2009; 11: 402.
39. Hellman A, Zlotorynski E, Scherer SW, et al. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 2002; 1: 89-97. (Pubitemid 41039179)
40. Helmrich A, Stout-Weider K, Hermann K, et al. Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes. Genome Res 2006; 16: 1222-30. (Pubitemid 44506955)
41. Chotteau-Lelievre A, Montesano R, Soriano J, et al. PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro. Dev Biol 2003; 259: 241-57. (Pubitemid 36836143)
42. Kurpios NA, MacNeil L, Shepherd TG, et al. The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development. Dev Biol 2009; 325: 106-21.
43. Gastaldi S, Sassi F, Accornero P, et al. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. Oncogene 2012. doi: 10.1038/onc.2012.154.
44. Garner OB, Bush KT, Nigam KB, et al. Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling. Dev Biol 2011; 355: 394-403.
45. Nelson CM, Vanduijn MM, Inman JL, et al. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 2006; 314: 298-300. (Pubitemid 44571974)
46. Aupperlee MD, Drolet AA, Durairaj S, et al. Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. Endocrinology 2009; 150: 1485-94.
47. Blackburn AC, Brown JS, Naber SP, et al. BALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- mice. Cancer Res 2003; 63: 2364-8. (Pubitemid 36605169)
48. McLachlan E, Shao Q, Laird DW,. Connexins and gap junctions in mammary gland development and breast cancer progression. J Membr Biol 2007; 218: 107-21. (Pubitemid 350132123)
49. Schade B, Rao T, Dourdin N, et al. PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis. J Biol Chem 2009; 284: 19018-26.